when intellia therapeutics submit bla for lonvo-z
before September
when intellia therapeutics submit bla for lonvo-z. Best Yes near 0¢ across 1 platform. Live cross-platform prices. Not financial advice.
Best Yes: 0¢ · Best No: 100¢ · 1 platform
- Kalshi: Yes 0¢ / No 100¢
TRADING OPEN
before September
Volume
$1.9K
$0 24h
Platforms
1
Cross-platform pricing
Resolution
Resolved
~0 days left
Category
Culture
Yes
0¢
Kalshi
No
100¢
Kalshi
Opens on best-price platform
Compare & Trade
1 platform
Price History
Loading…
About This Market
If Intellia Therapeutics, Inc. submits a BLA for Lonvoguran Ziclumeran (lonvo-z) to the FDA before Sep 1, 2026, then the market resolves to Yes.
Market Details
ResolutionResolved
Time Left0 days
StatusCLOSED
CategoryCulture
Yes
0¢
Kalshi
Payout Infinityx
No
100¢
Kalshi
Payout 1.0x
Opens on best-price platform
Compare & Trade
1 platformSign in to join the discussion
Sign In